Betafuse vet.

1 x 15 g

Gel

Active substance

Fusidic acid (Fusidic acid hemihydrate) : 5 mg/g

Betamethasone (Betamethason valerate) : 1 mg/g

ATC code

QD07CC01 Betamethasone (Corticosteroids - potent (group III)) and antibiotics

QD07CC Corticosteroids - potent (group III)) comb. with antibiotics

QD07C Corticosteroids, comb. with antibiotics

QD07 Corticosteroids, dermatological preparations

QD Dermatologicals

Species

Dogs.

Indications

For the treatment of acute surface pyoderma, such as acute moist dermatitis (‘hot spots’) and intertrigo (skin fold dermatitis), caused by Gram-positive bacteria sensitive to fusidic acid.

Dose to be administered and administration route

Cutaneous use.

First, the hairs covering the lesions should be gently clipped. The affected area should then be thoroughly cleaned with an antiseptic wash before daily application of the gel. The amount applied should cover the affected area in a thin layer. Apply approximately 0.5 cm length of gel per 8 cm² of lesion, twice daily, for a minimum period of 5 days. Treatment should continue for 48 hours after the lesion has resolved. The treatment period should not exceed 7 days. If there is no response within three days, or the condition deteriorates, the diagnosis should be re-evaluated.

Adverse reactions

Prolonged and intensive use of topical corticosteroid preparations or treatment of a large cutaneous surface (>10%) is known to trigger local or systemic effects including suppression of adrenal function, thinning of the epidermis and delayed healing.

Locally applied steroids may cause depigmentation of the skin.

Discontinue use if hypersensitivity develops to the product.